209 related articles for article (PubMed ID: 20890867)
21. Proscribed drugs at the Olympic Games: permitted use and misuse (doping) by athletes.
Fitch K
Clin Med (Lond); 2012 Jun; 12(3):257-60. PubMed ID: 22783779
[TBL] [Abstract][Full Text] [Related]
22. [Growth hormone and IGF-1 as doping agents in competitive sport].
Jóźków P; Medraś M
Endokrynol Pol; 2009; 60(5):389-94. PubMed ID: 19885810
[TBL] [Abstract][Full Text] [Related]
23. Growth hormone, IGF-I and insulin and their abuse in sport.
Holt RI; Sönksen PH
Br J Pharmacol; 2008 Jun; 154(3):542-56. PubMed ID: 18376417
[TBL] [Abstract][Full Text] [Related]
24. Supplement use in the adolescent athlete.
DesJardins M
Curr Sports Med Rep; 2002 Dec; 1(6):369-73. PubMed ID: 12831686
[TBL] [Abstract][Full Text] [Related]
25. Hormone abuse in sports: the antidoping perspective.
Barroso O; Mazzoni I; Rabin O
Asian J Androl; 2008 May; 10(3):391-402. PubMed ID: 18385901
[TBL] [Abstract][Full Text] [Related]
26. Growth hormone and physical performance.
Birzniece V; Nelson AE; Ho KK
Trends Endocrinol Metab; 2011 May; 22(5):171-8. PubMed ID: 21420315
[TBL] [Abstract][Full Text] [Related]
27. [Doping].
Kamber M; Villard G
Praxis (Bern 1994); 1995 Sep; 84(36):970-7. PubMed ID: 7481289
[TBL] [Abstract][Full Text] [Related]
28. Performance-enhancing drugs.
Dandoy C; Gereige RS
Pediatr Rev; 2012 Jun; 33(6):265-71; quiz 271-2. PubMed ID: 22659257
[No Abstract] [Full Text] [Related]
29. Can anabolic steroids or human growth hormone affect the growth and maturation of adolescent athletes?
Rogol AD
Pediatr Exerc Sci; 2014 Nov; 26(4):423-7. PubMed ID: 25372376
[No Abstract] [Full Text] [Related]
30. Statistical methodology for age-adjustment of the GH-2000 score detecting growth hormone misuse.
Böhning D; Böhning W; Guha N; Cowan DA; Sönksen PH; Holt RI
BMC Med Res Methodol; 2016 Oct; 16(1):147. PubMed ID: 27793179
[TBL] [Abstract][Full Text] [Related]
31. Ergogenic aids: a review of basic science, performance, side effects, and status in sports.
Tokish JM; Kocher MS; Hawkins RJ
Am J Sports Med; 2004 Sep; 32(6):1543-53. PubMed ID: 15310585
[TBL] [Abstract][Full Text] [Related]
32. Performance-enhancing drug use in young athletes.
Laos C; Metzl JD
Adolesc Med Clin; 2006 Oct; 17(3):719-31; abstract xii. PubMed ID: 17030288
[TBL] [Abstract][Full Text] [Related]
33. Does the GH-IGF axis play a role in cancer pathogenesis?
Cohen P; Clemmons DR; Rosenfeld RG
Growth Horm IGF Res; 2000 Dec; 10(6):297-305. PubMed ID: 11161960
[TBL] [Abstract][Full Text] [Related]
34. Sports pharmacology and ergogenic aids.
Ellender L; Linder MM
Prim Care; 2005 Mar; 32(1):277-92. PubMed ID: 15831323
[TBL] [Abstract][Full Text] [Related]
35. Possibility of enhanced risk of retinal angiogenesis in athletes with pre- existing retinal situation abusing erythropoietin doping: a hypothesis.
Rastmanesh R
Curr Drug Saf; 2012 Apr; 7(2):164-9. PubMed ID: 22873500
[TBL] [Abstract][Full Text] [Related]
36. Growth Hormone and Insulin-Like Growth Factor-1.
Nicholls AR; Holt RI
Front Horm Res; 2016; 47():101-14. PubMed ID: 27347885
[TBL] [Abstract][Full Text] [Related]
37. IGFs and human cancer: implications regarding the risk of growth hormone therapy.
Shim M; Cohen P
Horm Res; 1999; 51 Suppl 3():42-51. PubMed ID: 10592443
[TBL] [Abstract][Full Text] [Related]
38. [Doctors belonging to the Senegalese Association of Sport Medicine and doping in sports: survey on knowledge and attitudes].
Dièye AM; Diallo B; Fall A; Ndiaye M; Cissè F; Faye B
Sante; 2005; 15(3):167-70. PubMed ID: 16207578
[TBL] [Abstract][Full Text] [Related]
39. Growth hormone and the adolescent athlete: What are the data for its safety and efficacy as an ergogenic agent?
Rogol AD
Growth Horm IGF Res; 2009 Aug; 19(4):294-9. PubMed ID: 19487146
[TBL] [Abstract][Full Text] [Related]
40. Performance-enhancing drugs, fair competition, and Olympic sport.
Catlin DH; Murray TH
JAMA; 1996 Jul; 276(3):231-7. PubMed ID: 8667569
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
